Antiaggregatory effects of thromboxane receptor antagonists in vivo-Reference-Cited by-同舟云学术

Antiaggregatory effects of thromboxane receptor antagonists in vivo

Published:1985-12 Issue:5 Volume:40 Page:663-675
ISSN:0049-3848
Container-title:Thrombosis Research
language:en
Short-container-title:Thrombosis Research

Author:

Darius Harald,Lefer Allan M.

Publisher

Elsevier BV

Subject

Hematology

Reference19 articles.

1. Clinical aspects of the arachidonic acid-thromboxane pathway;Mitchell;Brit. Med. Bull.,1983

2. The thromboxanes;Granstrom,1983

3. Role of prostaglandins and thromboxanes in shock states;Lefer,1983

4. In vivo interaction of prostacyclin with an inhibitor of cyclic nucleotide phosphodiesterase, HL 725;Darius;Brit. J. Pharmacol,1985

5. Synthesis and biological properties of pinane thromboxane A2, a selective inhibitor of coronary artery constriction, platelet aggregation and thromboxane formation;Nicolaou,1979

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PHOSPHODIESTERASE INHIBITORS PIROXIMONE AND ENOXIMONE INHIBIT PLATELET AGGREGATION IN VIVO AND IN VITRO;Thrombosis Research;1997-10

2. Effect of Thromboxane A 2 Blockade on Clinical Outcome and Restenosis After Successful Coronary Angioplasty;Circulation;1995-12

3. Inhibitors of Fatty Acid-Derived Mediators;Lipid Mediators;1994

4. THE EFFECTS OF THROMBOXANE INHIBITORS ON THE MICROVASCULAR AND TUMOR RESPONSE TO PHOTODYNAMIC THERAPY;Photochemistry and Photobiology;1993-09

5. Synergistic platelet antiaggregatory effects of the adenylate cyclase activator iloprost and the guanylate cyclase activating agent SIN-1 in vivo;Thrombosis Research;1993-06